| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029383 |
| Receipt No. | R000033547 |
| Official scientific title of the study | Examination of influence of changing dialysate calcium concentration on bone mineral metabolism, nutritional status and prognosis in hemodialysis patients |
| Date of disclosure of the study information | 2017/10/10 |
| Last modified on | 2017/10/02 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Examination of influence of changing dialysate calcium concentration on bone mineral metabolism, nutritional status and prognosis in hemodialysis patients | |
| Title of the study (Brief title) | dialysate calcium concentration and bone mineral metabolism, nutritional status or prognosis | |
| Region |
|
|
| Condition | |||
| Condition | chronic kidney disease - mineral and bone disorder | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the influence of changes in dialysate calcium concentration on bone mineral metabolism in hemodialysis patients |
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the influence of changes in dialysate calcium concentration on nutritional status, and prognosis in hemodialysis patients |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Serum Ca, Pi, intact parathyroid hormone levels
Bone metabolism markers Mortality |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Hemodialysis patient | |||
| Key exclusion criteria | Under 18 y.o and more than 90 y.o. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroki Niwa |
| Organization | Iwata city Hospital |
| Division name | Renal Division |
| Address | 512-3 Ohkubo, Iwata, Shizuoka |
| TEL | 0538-38-5000 |
| niwahiroki77@gmail.com | |
| Public contact | |
| Name of contact person | Hiroki Niwa |
| Organization | Iwata City Hospital |
| Division name | Renal Division |
| Address | 512-3 Ohkubo, Iwata, Shizuoka |
| TEL | 0538-38-5000 |
| Homepage URL | |
| niwahiroki77@gmail.com | |
| Sponsor | |
| Institute | Iwata City Hospital
Renal Division |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self sourcing |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Study design; Prospective observation test
Subjects; patients undergoing HD in our institution at April 2016 Measurement; TRACP-5b, BAP, intact PTH levels in blood |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033547 |